Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and empathy/emotion recognition in healthy and antisocial adolescents
2016-000367-16Phase 4Terminated
- Sponsor
- Radboud University
- Start
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxytocin in antisocial personality disorder (ASPD), conduct disorder (CD) and post-traumatic stress disorder (PTSD) (3 arms), sponsored by Radboud University. Primary endpoints: Change in empathy score, Change in emotion recognition accuracy and 1 more. Started Oct 2016; status: terminated.
02
Drugs
oxytocin
03
Conditions
antisocial personality disorder (ASPD)conduct disorder (CD)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2016-000367-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000367-16.